The first batches of cpn-10 were manufactured in 2002 by Acyte Biotech in Sydney,at the department of Biotechnology in the University of New South Wales(a subsidiary of the university).In 2004 Cbio acquired a 48% holding in BresaGen Ltd.an Adelaide based specialist company (Administrators appointed) where Cbio will control BresGen and BresaGen shares will be relisted on the ASX.This company then went on to produce CPN10 for trials. Cbio's holdings in Bresagen were later onsold . This brings me to the point where we were told on numerous occasions that one of the highlights in the manufacturing of cpn10 was that it was "cheap" to make. I am sure that other share holders around this time would remember.
IVX Price at posting:
7.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)